BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bayraktar UD, Seren S, Bayraktar Y. Hepatic venous outflow obstruction: Three similar syndromes. World J Gastroenterol 2007; 13(13): 1912-1927 [PMID: 17461490 DOI: 10.3748/wjg.v13.i13.1912] [Cited by in CrossRef: 81] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Brisco MA, McCauley BD, Chen J, Parikh CR, Testani JM. Biochemical evidence of mild hepatic dysfunction identifies decompensated heart failure patients with reversible renal dysfunction. J Card Fail 2013;19:739-45. [PMID: 24263117 DOI: 10.1016/j.cardfail.2013.10.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ahmadzadehfar H, Biersack HJ, Ezziddin S. Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med. 2010;40:105-121. [PMID: 20113679 DOI: 10.1053/j.semnuclmed.2009.11.001] [Cited by in Crossref: 115] [Cited by in F6Publishing: 97] [Article Influence: 10.5] [Reference Citation Analysis]
3 Wu XW, Wang WQ, Liu B, Xu JM, Yu YQ, Zhang S, Shen Y. Hepatic veno-occlusive disease after taking Gynura Rhizome: The value of multidetector computed tomography in diagnosing the disease and evaluating the clinical therapeutic effect. Hepatol Res 2012;42:304-9. [PMID: 22136416 DOI: 10.1111/j.1872-034X.2011.00918.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhang Y, Yan Y, Song B. Noninvasive imaging diagnosis of sinusoidal obstruction syndrome: a pictorial review. Insights Imaging 2019;10:110. [PMID: 31748956 DOI: 10.1186/s13244-019-0791-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Faraoun SA, Boudjella Mel A, Debzi N, Benidir N, Afredj N, Guerrache Y, Bentabak K, Soyer P, Bendib SE. Budd-Chiari syndrome: an update on imaging features. Clin Imaging 2016;40:637-46. [PMID: 27317208 DOI: 10.1016/j.clinimag.2016.01.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
6 Karnsakul W, Ingviya T, Seaberg E, Laengvejkal P, Imteyaz H, Vasilescu A, Schwarz KB, Scheimann AO. Ascites in Children: A Single-Center Experience of 27 Years. J Pediatr Gastroenterol Nutr 2017;64:83-8. [PMID: 27050055 DOI: 10.1097/MPG.0000000000001209] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 3.7] [Reference Citation Analysis]
7 Abu-Toamih Atamni HJ, Botzman M, Mott R, Gat-Viks I, Iraqi FA. Mapping novel genetic loci associated with female liver weight variations using Collaborative Cross mice. Animal Model Exp Med 2018;1:212-20. [PMID: 30891567 DOI: 10.1002/ame2.12036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dogan Y, Soylu A, Kilickesmez O, Demirtas T, Kilickesmez KO, Dogan SN, Eren G, Sevindir I, Yasar N, Poturoglu S, Sonmez K. The value of hepatic diffusion-weighted MR imaging in demonstrating hepatic congestion secondary to pulmonary hypertension. Cardiovasc Ultrasound 2010;8:28. [PMID: 20663149 DOI: 10.1186/1476-7120-8-28] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
9 Luo S, Chu J, Huang H, Yao K. Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids. Biomed Res Int 2018;2018:9804582. [PMID: 30009181 DOI: 10.1155/2018/9804582] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Grimm JC, Magruder JT, Do N, Spinner JA, Dungan SP, Kilic A, Patel N, Nelson KL, Jacobs ML, Cameron DE, Vricella LA. Modified Model for End-Stage Liver Disease eXcluding INR (MELD-XI) Score Predicts Early Death After Pediatric Heart Transplantation. Ann Thorac Surg 2016;101:730-5. [PMID: 26347119 DOI: 10.1016/j.athoracsur.2015.06.063] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
11 Heimbach T, Chen Y, Chen J, Dixit V, Parrott N, Peters SA, Poggesi I, Sharma P, Snoeys J, Shebley M, Tai G, Tse S, Upreti VV, Wang YH, Tsai A, Xia B, Zheng M, Zhu AZX, Hall S. Physiologically-Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective. Clin Pharmacol Ther 2021;110:297-310. [PMID: 33270249 DOI: 10.1002/cpt.2125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
12 Wang L, Lu JP, Wang F, Liu Q, Wang J. Diagnosis of Budd-Chiari syndrome: three-dimensional dynamic contrast enhanced magnetic resonance angiography. Abdom Imaging. 2011;36:399-406. [PMID: 21399974 DOI: 10.1007/s00261-011-9724-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
13 Sangro B, Gil-alzugaray B, Rodriguez J, Sola I, Martinez-cuesta A, Viudez A, Chopitea A, Iñarrairaegui M, Arbizu J, Bilbao JI. Liver disease induced by radioembolization of liver tumors: Description and possible risk factors. Cancer 2008;112:1538-46. [DOI: 10.1002/cncr.23339] [Cited by in Crossref: 232] [Cited by in F6Publishing: 184] [Article Influence: 17.8] [Reference Citation Analysis]
14 Seidensticker R, Seidensticker M, Damm R, Mohnike K, Schütte K, Malfertheiner P, Van Buskirk M, Pech M, Amthauer H, Ricke J. Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach. Cardiovasc Intervent Radiol. 2012;35:1109-1118. [PMID: 22037709 DOI: 10.1007/s00270-011-0295-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
15 Kobryń K, Paluszkiewicz R, Dudek K, Ołdakowska-Jedynak U, Korba M, Raszeja-Wyszomirska J, Remiszewski P, Grąt M, Milkiewicz P, Patkowski W, Krawczyk M. Good outcome following liver transplantation using pericardial-peritoneum window for hepato-atrial anastomosis to overcome advanced hepatic alveolar echinococcosis and secondary Budd-Chiari Syndrome - a case report. BMC Surg 2017;17:5. [PMID: 28086841 DOI: 10.1186/s12893-017-0205-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yang XQ, Ye J, Li X, Li Q, Song YH. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes. World J Gastroenterol 2019; 25(28): 3753-3763 [PMID: 31391770 DOI: 10.3748/wjg.v25.i28.3753] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
17 Long J, Vaughan-Williams H, Moorhouse J, Sethi H, Kumar N. Acute Budd-Chiari syndrome due to a simple liver cyst. Ann R Coll Surg Engl 2014;96:109E-11E. [PMID: 24417858 DOI: 10.1308/003588414X13824511649698] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
18 Barbier L, Ronot M, Aussilhou B, Cauchy F, Francoz C, Vilgrain V, Soubrane O, Paradis V, Belghiti J. Polycystic liver disease: Hepatic venous outflow obstruction lesions of the noncystic parenchyma have major consequences. Hepatology. 2018;68:652-662. [PMID: 29023812 DOI: 10.1002/hep.29582] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
19 Faraoun SA, Boudjella Mel A, Debzi N, Afredj N, Guerrache Y, Benidir N, Bouzid C, Bentabak K, Soyer P, Bendib SE. Budd-Chiari syndrome: a prospective analysis of hepatic vein obstruction on ultrasonography, multidetector-row computed tomography and MR imaging. Abdom Imaging. 2015;40:1500-1509. [PMID: 25687630 DOI: 10.1007/s00261-015-0380-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
20 Shang H, Bai T, Zhu S, Yang X, Liu C, Xu D, Zhuge Y, Song Y, Hou X. Prognostic factors for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: a multicenter study in China. Ann Transl Med 2021;9:11. [PMID: 33553304 DOI: 10.21037/atm-20-731] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Crawford JM. Vascular disorders of the liver. Clin Liver Dis. 2010;14:635-650. [PMID: 21055687 DOI: 10.1016/j.cld.2010.08.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
22 Cheng DL, Zhu N, Li CL, Lv WF, Fang WW, Liu Y, Li CT. Significance of malondialdehyde, superoxide dismutase and endotoxin levels in Budd-Chiari syndrome in patients and a rat model. Exp Ther Med 2018;16:5227-35. [PMID: 30542478 DOI: 10.3892/etm.2018.6835] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Gewehr DM, Giovanini AF, Munhoz SI, Nagashima S, Bertoldi AS, Sobral ACL, Kubrusly FB, Kubrusly LF. SOFTWARE-ASSISTED IMAGE ANALYSIS FOR IDENTIFICATION AND QUANTIFICATION OF HEPATIC SINUSOIDAL DILATATION AND CENTRILOBULAR FIBROSIS. Arq Bras Cir Dig 2021;34:e1608. [PMID: 34669894 DOI: 10.1590/0102-672020210002e1608] [Reference Citation Analysis]
24 Weisse C, Scansen BA, Berent AC, Cober RE. Transatrial stenting for long-term management of cardiac tumor obstruction of the right atrium in 3 dogs. J Vet Intern Med 2021;35:120-9. [PMID: 33338301 DOI: 10.1111/jvim.15999] [Reference Citation Analysis]
25 Furlan A, Minervini MI, Borhani AA, Dioguardi Burgio M, Tublin ME, Brancatelli G. Hepatic Sinusoidal Dilatation: A Review of Causes With Imaging-Pathologic Correlation. Seminars in Ultrasound, CT and MRI 2016;37:525-32. [DOI: 10.1053/j.sult.2016.08.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
26 Grimm JC, Shah AS, Magruder JT, Kilic A, Valero V, Dungan SP, Tedford RJ, Russell SD, Whitman GJ, Sciortino CM. MELD-XI Score Predicts Early Mortality in Patients After Heart Transplantation. Ann Thorac Surg. 2015;100:1737-1743. [PMID: 26387720 DOI: 10.1016/j.athoracsur.2015.07.026] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
27 Nayak SB, Deepthinath R, Kumar N, Shetty P, Kumar V, Aithal A, Shetty SD. Evaluation of Numerical and Positional Variations of the Hepatic Veins: A Cadaveric Study. J Cardiovasc Echogr. 2016;26:5-10. [PMID: 28465952 DOI: 10.4103/2211-4122.178468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Wang Y, Qiao D, Li Y, Xu F. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study. BMC Gastroenterol. 2018;18:156. [PMID: 30367628 DOI: 10.1186/s12876-018-0879-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
29 Fang CH, You JH, Lau WY, Lai EC, Fan YF, Zhong SZ, Li KX, Chen ZX, Su ZH, Bao SS. Anatomical variations of hepatic veins: three-dimensional computed tomography scans of 200 subjects. World J Surg. 2012;36:120-124. [PMID: 21976007 DOI: 10.1007/s00268-011-1297-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
30 Gonzalez RS, Gilger MA, Huh WJ, Washington MK. The Spectrum of Histologic Findings in Hepatic Outflow Obstruction. Arch Pathol Lab Med 2017;141:98-103. [PMID: 27681331 DOI: 10.5858/arpa.2015-0388-OA] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
31 Gil-alzugaray B, Chopitea A, Iñarrairaegui M, Bilbao JI, Rodriguez-fraile M, Rodriguez J, Benito A, Dominguez I, D'avola D, Herrero JI, Quiroga J, Prieto J, Sangro B. Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology 2013;57:1078-87. [DOI: 10.1002/hep.26191] [Cited by in Crossref: 151] [Cited by in F6Publishing: 130] [Article Influence: 18.9] [Reference Citation Analysis]
32 El Sebay HM, Safan MA, Daoud AA, Tayel SI, A Nouh M, El Shafie S. Association of factor V Leiden, Janus kinase 2, prothrombin, and MTHFR mutations with primary Budd-Chiari syndrome in Egyptian patients: Thrombophilia genes in Budd Chiari. Journal of Gastroenterology and Hepatology 2016;31:235-40. [DOI: 10.1111/jgh.13066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
33 Cefalo MG, Maurizi P, Arlotta A, Scalzone M, Attinà G, Ruggiero A, Riccardi R. Hepatic veno-occlusive disease: a chemotherapy-related toxicity in children with malignancies. Paediatr Drugs 2010;12:277-84. [PMID: 20799757 DOI: 10.2165/11531840-000000000-00000] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
34 Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, Brezault C, Soubrane O, Abdalla EK, Vauthey JN, Mentha G, Terris B. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology. 2010;56:430-439. [PMID: 20459550 DOI: 10.1111/j.1365-2559.2010.03511.x] [Cited by in Crossref: 207] [Cited by in F6Publishing: 180] [Article Influence: 20.7] [Reference Citation Analysis]
35 Vinchi F, Gastaldi S, Silengo L, Altruda F, Tolosano E. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am J Pathol 2008;173:289-99. [PMID: 18556779 DOI: 10.2353/ajpath.2008.071130] [Cited by in Crossref: 86] [Cited by in F6Publishing: 82] [Article Influence: 6.6] [Reference Citation Analysis]
36 Hoff PM, Saad ED, Costa F, Coutinho AK, Caponero R, Prolla G, Gansl RC. Literature review and practical aspects on the management of oxaliplatin-associated toxicity. Clin Colorectal Cancer 2012;11:93-100. [PMID: 22154408 DOI: 10.1016/j.clcc.2011.10.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
37 Kawaguchi Y, Ishizawa T, Miyata Y, Yamashita S, Masuda K, Satou S, Tamura S, Kaneko J, Sakamoto Y, Aoki T, Hasegawa K, Sugawara Y, Kokudo N. Portal uptake function in veno-occlusive regions evaluated by real-time fluorescent imaging using indocyanine green. J Hepatol. 2013;58:247-253. [PMID: 23041306 DOI: 10.1016/j.jhep.2012.09.028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 57] [Article Influence: 8.1] [Reference Citation Analysis]
38 Fortea JI, Puente Á, Cuadrado A, Huelin P, Pellón R, González Sánchez FJ, Mayorga M, Cagigal ML, García Carrera I, Cobreros M, Crespo J, Fábrega E. Congestive Hepatopathy. Int J Mol Sci 2020;21:E9420. [PMID: 33321947 DOI: 10.3390/ijms21249420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Varma A, Abraham SC, Mehta RS, Saini NY, Honhar M, Rashid M, Chen J, Srour SA, Bashir Q, Rondon G, Oran B, Hosing CM, Nieto Y, Kebriaei P, Alousi AM, Ahmed S, Marin D, Khouri IF, Ciurea SO, Qazilbash MH, Rezvani K, Anderlini P, Andersson BS, Shpall EJ, Champlin RE, Popat UR. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity. Blood Adv 2020;4:1296-306. [PMID: 32236526 DOI: 10.1182/bloodadvances.2019000638] [Reference Citation Analysis]
40 Butzko R, Narasimhan M. Acute Budd Chiari syndrome in an ECMO patient. Perfusion 2021;:2676591211003874. [PMID: 33769103 DOI: 10.1177/02676591211003874] [Reference Citation Analysis]
41 Delicque J, Boulin M, Guiu B, Pelage J, Escal L, Schembri V, Assenat E, Fohlen A. Interventional oncology for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2016;40:530-7. [DOI: 10.1016/j.clinre.2016.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
42 Kan X, Ye J, Rong X, Lu Z, Li X, Wang Y, Yang L, Xu K, Song Y, Hou X. Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome. Sci Rep. 2016;6:37998. [PMID: 27897243 DOI: 10.1038/srep37998] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
43 Yang JA, Kato TS, Shulman BP, Takayama H, Farr M, Jorde UP, Mancini DM, Naka Y, Schulze PC. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant 2012;31:601-10. [PMID: 22458997 DOI: 10.1016/j.healun.2012.02.027] [Cited by in Crossref: 111] [Cited by in F6Publishing: 89] [Article Influence: 12.3] [Reference Citation Analysis]
44 Di Serafino M, Severino R, Gioioso M, Rossi E, Vezzali N, Pelliccia P, Caprio MG, Acampora C, Iorio R, Vallone G. Paediatric liver ultrasound: a pictorial essay. J Ultrasound 2020;23:87-103. [PMID: 30778891 DOI: 10.1007/s40477-018-0352-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
45 Radosa CG, Radosa JC, Grosche-Schlee S, Zöphel K, Plodeck V, Kühn JP, Kotzerke J, Hoffmann RT. Holmium-166 Radioembolization in Hepatocellular Carcinoma: Feasibility and Safety of a New Treatment Option in Clinical Practice. Cardiovasc Intervent Radiol 2019;42:405-12. [PMID: 30603976 DOI: 10.1007/s00270-018-2133-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
46 Chen B, Schreiber RA, Human DG, Potts JE, Guttman OR. Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography. Can J Gastroenterol Hepatol 2016;2016:7125193. [PMID: 27656638 DOI: 10.1155/2016/7125193] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
47 Bernts LHP, Tjwa ETTL, D'Agnolo HMA, Jenniskens SFM, Drenth JPH. Venous Stent Placement for Refractory Ascites due to Hepatic Venous Outflow Obstruction in Polycystic Liver Disease. J Vasc Interv Radiol. 2019;30:1617-1619. [PMID: 31005489 DOI: 10.1016/j.jvir.2018.09.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Abdel Hameed MR, Elbeih EAS, Abd El-Aziz HM, Afifi OA, Khalaf LMR, Ali Abu Rahma MZ, Sabry A. Epidemiological Characteristics and Etiology of Budd-Chiari Syndrome in Upper Egypt. J Blood Med 2020;11:515-24. [PMID: 33408545 DOI: 10.2147/JBM.S278678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Lee HJ, Kim KW, Mun HS, Kim JH, Song GW, Hwang S, Lee SG. Uncommon causes of hepatic congestion in patients after living donor liver transplantation. AJR Am J Roentgenol 2009;193:772-80. [PMID: 19696292 DOI: 10.2214/AJR.08.1782] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
50 Majumder K, Spratt JR, Holley CT, Roy SS, Cogswell RJ, Liao K, John R. Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device Implantation. The Annals of Thoracic Surgery 2017;104:1556-62. [DOI: 10.1016/j.athoracsur.2017.04.048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
51 Paul SB, Shalimar, Sreenivas V, Gamanagatti SR, Sharma H, Dhamija E, Acharya SK. Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction. Aliment Pharmacol Ther. 2015;41:961-971. [PMID: 25809735 DOI: 10.1111/apt.13173] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
52 Hidaka H, Iwakiri Y. Hepatic congestion leads to fibrosis: findings in a newly developed murine model. Hepatology 2015;61:428-30. [PMID: 25283276 DOI: 10.1002/hep.27550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
53 Zhuang Y, Zu M, Li J, Wang Y, Han C, Zhang Q, Xu W, Wei N, Xu K. Serum Iodine Is Increased in Subjects Having Budd–Chiari Syndrome. Biol Trace Elem Res 2015;168:21-4. [DOI: 10.1007/s12011-015-0343-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Graber I, Dumortier J, Poncet G, Queneau PE, Mathevet P, Scoazec JY. Hepar lobatum carcinomatosum revealing an occult metastatic lobular carcinoma of the breast. Ann Diagn Pathol 2010;14:438-42. [PMID: 21074693 DOI: 10.1016/j.anndiagpath.2009.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
55 Urahashi T, Mizuta K, Ihara Y, Sanada Y, Wakiya T, Yamada N, Okada N. Impact of post-transplant flow cytometric panel-reactive antibodies on late-onset hepatic venous outflow obstruction following pediatric living donor liver transplantation. Transpl Int 2014;27:322-9. [DOI: 10.1111/tri.12255] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
56 Taş A, Kara B, Yılmaz C, Suat Yalçın M, Dilek O, Olmez S, Saritas B. Fulminant Budd-Chiari syndrome due to ecstasy. Clin Res Hepatol Gastroenterol 2017;41:e12-3. [PMID: 27459877 DOI: 10.1016/j.clinre.2016.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
57 Rubbia-Brandt L. Sinusoidal obstruction syndrome. Clin Liver Dis. 2010;14:651-668. [PMID: 21055688 DOI: 10.1016/j.cld.2010.07.009] [Cited by in Crossref: 60] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
58 Weiskirchen R, Weiskirchen S, Tacke F. Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. F1000Res 2018;7:F1000 Faculty Rev-921. [PMID: 30002817 DOI: 10.12688/f1000research.14841.1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 13.7] [Reference Citation Analysis]
59 Kubo T, Kiryu S, Akai H, Ota Y, Tojo A, Yoshida H, Kato N, Nakano Y, Ohtomo K. Hepatic Involvement of Histiocytic Sarcoma: CT and MRI Findings. Korean J Radiol 2016;17:758-62. [PMID: 27587965 DOI: 10.3348/kjr.2016.17.5.758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]